Rankings
▼
Calendar
DNA FY 2021 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$418M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$314M
+309.4% YoY
Gross Profit
$184M
58.7% margin
Operating Income
-$1.8B
-582.6% margin
Net Income
-$1.8B
-583.1% margin
EPS (Diluted)
$-55.53
Cash Flow
Operating Cash Flow
-$254M
Free Cash Flow
-$310M
Stock-Based Comp.
$1.6B
Balance Sheet
Total Assets
$2.1B
Total Liabilities
$504M
Stockholders' Equity
$1.5B
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$314M
$77M
+309.4%
Gross Profit
$184M
$61M
+201.7%
Operating Income
-$1.8B
-$137M
-1234.4%
Net Income
-$1.8B
-$127M
-1345.4%
← Q4 2020
All Quarters
Q1 2021 →